Cumberland Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview

Cumberland Pharmaceuticals

07/08/2021 03:03

* Cumberland Pharmaceuticals Inc  CPIX.OQ   CPIX.O  is expected
to show a fall in quarterly revenue when it reports results on
August 10. 
* The Nashville, Tennessee-based company is expected to report 
 a 10.7% decrease in revenue to $8.571 million from $9.6 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Cumberland
Pharmaceuticals Inc is for a loss of 7 cents per share. For the
same quarter last year, the company reported earnings of 8 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Cumberland
Pharmaceuticals Inc is $8.5​, about 66% above​ its last closing
price of $2.89. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021              -0.07      0.07      Beat    200
 Dec. 31 2020  -0.01       -0.01      0.01      Beat    200
 Sep. 30 2020  -0.07       -0.07      0.02      Beat    128.6​
 Jun. 30 2020  0.03        0.03       0.08      Beat    166.7
 Mar.          0.02​       0.02       0.01      Missed  -50​
 31​ 2020​                                              
 Dec. 31 2019              0.01       0.09      Beat    800​
 Sep. 30 2019  0.11        0.11       0.01      Missed  -90.9
 Jun. 30 2019  0.07        0.07       0.10      Beat    42.9
 This summary was machine generated August 7 at 02:03 GMT.  All
figures in US dollars unless otherwise stated